• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Successful use of the interleukin 1 antagonist, anakinra, in a patient with gout, chronic kidney disease, and aplastic anemia.

作者信息

Bartov Janet Beth, Ali Yousaf

机构信息

From the *Center of Rheumatic Disease, Morristown Medical Center, Morristown, NJ; and †Division of Rheumatology, Mount Sinai School of Medicine, New York, NY.

出版信息

J Clin Rheumatol. 2013 Dec;19(8):454-6. doi: 10.1097/RHU.0000000000000047.

DOI:10.1097/RHU.0000000000000047
PMID:24263151
Abstract
摘要

相似文献

1
Successful use of the interleukin 1 antagonist, anakinra, in a patient with gout, chronic kidney disease, and aplastic anemia.白细胞介素1拮抗剂阿那白滞素在一名患有痛风、慢性肾病和再生障碍性贫血的患者中的成功应用。
J Clin Rheumatol. 2013 Dec;19(8):454-6. doi: 10.1097/RHU.0000000000000047.
2
Effectiveness and safety of anakinra in gout patients with stage 4-5 chronic kidney disease or kidney transplantation: A multicentre, retrospective study.阿那白滞素治疗 4-5 期慢性肾脏病或肾移植的痛风患者的有效性和安全性：一项多中心、回顾性研究。
Joint Bone Spine. 2018 Dec;85(6):755-760. doi: 10.1016/j.jbspin.2018.03.015. Epub 2018 Apr 11.
3
IL-1 inhibition with anakinra in a patient with refractory gout.用阿那白滞素抑制白细胞介素-1治疗一名难治性痛风患者。
J Clin Rheumatol. 2009 Oct;15(7):366. doi: 10.1097/RHU.0b013e3181be2423.
4
Case of anakinra as a steroid-sparing agent for gout inflammation.阿那白滞素作为痛风炎症甾体类药物替代剂的病例。
Arthritis Rheum. 2009 Sep 15;61(9):1268-70. doi: 10.1002/art.24694.
5
Anakinra's efficacy is variable in refractory gout: report of ten cases.阿那白滞素治疗难治性痛风的疗效不一：10 例报告。
Semin Arthritis Rheum. 2010 Dec;40(3):210-4. doi: 10.1016/j.semarthrit.2010.03.001. Epub 2010 May 21.
6
Interleukin-1 inhibition by anakinra in refractory chronic tophaceous gout.阿那白滞素治疗难治性慢性有结晶痛风
Int J Rheum Dis. 2011 Aug;14(3):e33-7. doi: 10.1111/j.1756-185X.2011.01629.x.
7
Anakinra in resistant gout: a case report.阿那白滞素治疗难治性痛风：一例报告
Acta Clin Belg. 2017 Aug;72(4):293-295. doi: 10.1080/17843286.2016.1239891. Epub 2016 Oct 7.
8
Tuberculous cervical lymphadenitis in a gouty patient treated with anakinra.用阿那白滞素治疗的痛风患者的结核性颈淋巴结炎
J Clin Rheumatol. 2015 Jun;21(4):230. doi: 10.1097/RHU.0000000000000254.
9
Effectiveness of Anakinra in Acute Gout: A Retrospective Review of Initial and Refractory Therapy.阿那白滞素治疗急性痛风的有效性：初始治疗与难治性治疗的回顾性分析
Am J Ther. 2017 Sep/Oct;24(5):e633-e634. doi: 10.1097/MJT.0000000000000524.
10
Efficacy but side effects of anakinra therapy for chronic refractory gout in a renal transplant recipient with preterminal chronic renal failure.阿那白滞素治疗终末期慢性肾衰竭肾移植受者慢性难治性痛风的疗效及副作用
Joint Bone Spine. 2012 Dec;79(6):631. doi: 10.1016/j.jbspin.2012.04.009. Epub 2012 Jul 26.

引用本文的文献

1
Effectiveness and safety of anakinra in gouty arthritis: A case series and review of the literature.阿那白滞素治疗痛风性关节炎的有效性和安全性：病例系列及文献综述
Front Med (Lausanne). 2023 Jan 12;9:1089993. doi: 10.3389/fmed.2022.1089993. eCollection 2022.
2
Efficacy and safety of gout flare prophylaxis and therapy use in people with chronic kidney disease: a Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN)-initiated literature review.慢性肾脏病患者痛风急性发作预防和治疗的疗效和安全性：痛风、高尿酸血症和晶体相关性疾病网络（G-CAN）发起的文献综述。
Arthritis Res Ther. 2021 Apr 28;23(1):130. doi: 10.1186/s13075-021-02416-y.
3
Anti-interleukin-1 treatment among patients with familial Mediterranean fever resistant to colchicine treatment. Retrospective analysis.
对秋水仙碱治疗耐药的家族性地中海热患者的抗白细胞介素-1治疗。回顾性分析。
Sao Paulo Med J. 2019 May 8;137(1):39-44. doi: 10.1590/1516-3180.2018.0311101218.
4
Gout increases risk of fracture: A nationwide population-based cohort study.痛风增加骨折风险：一项基于全国人群的队列研究。
Medicine (Baltimore). 2016 Aug;95(34):e4669. doi: 10.1097/MD.0000000000004669.